entertainment -WSS

entertainment

author：leisure time 2025-10-01 07:41:42 - browse：59

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The stability of $0 premiums in Medicare Advantage

focus

WSS

WHO recommends second malaria vaccine

A daunting task: navigating dual Medicare, Medicaid eligibility

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Anthos stroke drug appears safer than common blood thinner

The Karikó problem: Lessons for funding basic research

hotspot

entertainment

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Anthos stroke drug appears safer than common blood thinner

Dobbs anniversary: the lost opportunity of abortion as health care

New oral drug delivery patch is modeled after octopus tentacles

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Gain of function research would be limited under House proposal

BioMarin wins approval for gene therapy to treat hemophilia A

Surge of respiratory disease in China has likely explanation

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CRISPR pioneers react to Casgevy, first gene

focus

RSV injection headlines need to be accurate for good uptake

Flu, Covid vaccination rates decline, new survey data show

IVG is promising — but it won’t replace IVF quite yet

Nobel honors Karikó and Weissman's enduring partnership

Setback for rare diseases as Taysha Gene Therapies pulls back

The stability of $0 premiums in Medicare Advantage

focus

focus

entertainment

hotspot